Arctigenin
CAS 7770-78-7
Arctigenin (CAS 7770-78-7) is a pharmaceutical compound with 7 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 6774.618181818182 nM | 11 | - |
| - | IC50 | 8131.2 nM | 10 | - |
| - | AC50 | 15830.788 nM | 4 | - |
| - | EC50 | 37473.333333333336 nM | 3 | - |
| - | IC50 | 1.5666666666666667 ug.mL-1 | 3 | - |
| - | MIC | 63000 nM | 2 | - |
| - | EC50 | 1.85 ug.mL-1 | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| phosphodiesterase 4D PDE4D |
Inhibition | 5.420000076293945 pIC50 | 34603793 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Arctigenin used for in pharmaceutical contexts?
Arctigenin (CAS 7770-78-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Arctigenin?
No adverse-event association or SIDER side-effect rows are rendered for Arctigenin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Arctigenin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Arctigenin with EU status "permitted".
What clinical phase is Arctigenin in?
No phase 1-4 clinical development badge is rendered for Arctigenin because the matched compound identifier rows do not contain a max-phase value.